Search

Robert E. Mosser

Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )

Most Active Art Unit
3715
Art Unit(s)
3714, 3715, 3713, 3712
Total Applications
839
Issued Applications
347
Pending Applications
141
Abandoned Applications
372

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16367406 [patent_doc_number] => 10799138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-13 [patent_title] => Method of administering sotalol IV/switch [patent_app_type] => utility [patent_app_number] => 16/376706 [patent_app_country] => US [patent_app_date] => 2019-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 7453 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376706 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/376706
Method of administering sotalol IV/switch Apr 4, 2019 Issued
Array ( [id] => 15290411 [patent_doc_number] => 20190388341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => CHEWABLE GEL DOSAGE FORM AND ASSOCIATED METHODS [patent_app_type] => utility [patent_app_number] => 16/372177 [patent_app_country] => US [patent_app_date] => 2019-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34152 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16372177 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/372177
CHEWABLE GEL DOSAGE FORM AND ASSOCIATED METHODS Mar 31, 2019 Abandoned
Array ( [id] => 15144935 [patent_doc_number] => 20190350945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => USES OF OXYGENATED CHOLESTEROL SULFATES (OCS) [patent_app_type] => utility [patent_app_number] => 16/368553 [patent_app_country] => US [patent_app_date] => 2019-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21484 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16368553 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/368553
Uses of oxygenated cholesterol sulfates (OCS) Mar 27, 2019 Issued
Array ( [id] => 15206045 [patent_doc_number] => 20190365709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy [patent_app_type] => utility [patent_app_number] => 16/348630 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11418 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348630 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/348630
Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy Mar 20, 2019 Abandoned
Array ( [id] => 15524605 [patent_doc_number] => 20200054608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA [patent_app_type] => utility [patent_app_number] => 16/361085 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4269 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361085 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/361085
ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA Mar 20, 2019 Abandoned
Array ( [id] => 16688261 [patent_doc_number] => 20210070737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => ANTIVIRAL COMPOUNDS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/981346 [patent_app_country] => US [patent_app_date] => 2019-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18594 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981346 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/981346
Antiviral compounds and use thereof Mar 17, 2019 Issued
Array ( [id] => 14531525 [patent_doc_number] => 20190201383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts [patent_app_type] => utility [patent_app_number] => 16/297006 [patent_app_country] => US [patent_app_date] => 2019-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12006 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16297006 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/297006
Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts Mar 7, 2019 Abandoned
Array ( [id] => 14497741 [patent_doc_number] => 20190192525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => APILIMOD COMPOSITIONS AND METHODS FOR USING SAME [patent_app_type] => utility [patent_app_number] => 16/289963 [patent_app_country] => US [patent_app_date] => 2019-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289963 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/289963
APILIMOD COMPOSITIONS AND METHODS FOR USING SAME Feb 28, 2019 Abandoned
Array ( [id] => 16555685 [patent_doc_number] => 20210000833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => INHIBITION OF NSMASE FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 16/977309 [patent_app_country] => US [patent_app_date] => 2019-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16002 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977309 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/977309
Inhibition of nSMase for the treatment of human immunodeficiency virus infection Feb 28, 2019 Issued
Array ( [id] => 14497619 [patent_doc_number] => 20190192464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => BRANCHED CHAIN FATTY ACIDS FOR PREVENTION OR TREATMENT OF GASTROINTESTINAL DISORDERS [patent_app_type] => utility [patent_app_number] => 16/289214 [patent_app_country] => US [patent_app_date] => 2019-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289214 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/289214
BRANCHED CHAIN FATTY ACIDS FOR PREVENTION OR TREATMENT OF GASTROINTESTINAL DISORDERS Feb 27, 2019 Abandoned
Array ( [id] => 15813773 [patent_doc_number] => 10632043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-28 [patent_title] => Premix formulation for parenteral use and packaging thereof [patent_app_type] => utility [patent_app_number] => 16/285527 [patent_app_country] => US [patent_app_date] => 2019-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6920 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16285527 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/285527
Premix formulation for parenteral use and packaging thereof Feb 25, 2019 Issued
Array ( [id] => 14464481 [patent_doc_number] => 20190183880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => METHOD OF INHIBITING MUTANT C-KIT [patent_app_type] => utility [patent_app_number] => 16/283190 [patent_app_country] => US [patent_app_date] => 2019-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283190 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/283190
Method of inhibiting mutant C-KIT Feb 21, 2019 Issued
Array ( [id] => 16761000 [patent_doc_number] => 20210106581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => Treatment Of Liver Diseases [patent_app_type] => utility [patent_app_number] => 16/970543 [patent_app_country] => US [patent_app_date] => 2019-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970543 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/970543
Treatment Of Liver Diseases Feb 18, 2019 Abandoned
Array ( [id] => 16640788 [patent_doc_number] => 10918609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-16 [patent_title] => Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient [patent_app_type] => utility [patent_app_number] => 16/274478 [patent_app_country] => US [patent_app_date] => 2019-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8687 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274478 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/274478
Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient Feb 12, 2019 Issued
Array ( [id] => 16619913 [patent_doc_number] => 20210038566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => USE OF MODULATORS OF NEET PROTEINS FOR THE TREATMENT OF INFECTION [patent_app_type] => utility [patent_app_number] => 16/967752 [patent_app_country] => US [patent_app_date] => 2019-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967752 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/967752
USE OF MODULATORS OF NEET PROTEINS FOR THE TREATMENT OF INFECTION Feb 7, 2019 Abandoned
Array ( [id] => 14578297 [patent_doc_number] => 20190216757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => Methods for Cancer and Immunotherapy Using Prodrugs of Glutamine Analogs [patent_app_type] => utility [patent_app_number] => 16/262476 [patent_app_country] => US [patent_app_date] => 2019-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16262476 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/262476
Methods for cancer and immunotherapy using prodrugs of glutamine analogs Jan 29, 2019 Issued
Array ( [id] => 14336925 [patent_doc_number] => 20190150435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => MIXTURES OF SABADILLA ALKALOIDS AND PYRETHRUM AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/253327 [patent_app_country] => US [patent_app_date] => 2019-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2102 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16253327 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/253327
MIXTURES OF SABADILLA ALKALOIDS AND PYRETHRUM AND USES THEREOF Jan 21, 2019 Abandoned
Array ( [id] => 16197414 [patent_doc_number] => 10722550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-28 [patent_title] => Compositions and methods for the treatment of fungal infections [patent_app_type] => utility [patent_app_number] => 16/250612 [patent_app_country] => US [patent_app_date] => 2019-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 6465 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16250612 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/250612
Compositions and methods for the treatment of fungal infections Jan 16, 2019 Issued
Array ( [id] => 15510339 [patent_doc_number] => 10561736 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-02-18 [patent_title] => Apoptosis inhibitor formulations for prevention of hearing loss [patent_app_type] => utility [patent_app_number] => 16/243892 [patent_app_country] => US [patent_app_date] => 2019-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 16878 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 390 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16243892 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/243892
Apoptosis inhibitor formulations for prevention of hearing loss Jan 8, 2019 Issued
Array ( [id] => 17844897 [patent_doc_number] => 11434249 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-09-06 [patent_title] => ASK1 inhibitor compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 16/958053 [patent_app_country] => US [patent_app_date] => 2018-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42691 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958053 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/958053
ASK1 inhibitor compounds and uses thereof Dec 30, 2018 Issued
Menu